- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Cranial diabetes insipidus Primary nocturnal enuresis
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 437.6KB)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 95.2KB)
Desmopressin – November 2025
Desmopressin: Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations, 5 mL; Desmomed - November 2025
Last updated
5 November 2025